Figure 3.
Prevalence and cumulative incidence of primary and secondary endpoint tuberculosis
Prevalence and cumulative incidence of primary (A) and secondary (B) endpoint tuberculosis in RISK11-positive and RISK11-negative participants at study enrolment and over 15 months of follow-up. Error bars and shaded areas represent the 95% CIs.